Using recombination-dependent lethal mutations to stabilize reporter flaviviruses for rapid serodiagnosis and drug discovery is a research paper published in EBioMedicine (2020). On theSindex it has a DataRank of 0.515. It has been cited 30 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.515
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCATS NIH HHS
Grant: TL1 TR001440
NIAID NIH HHS
Grant: U19 AI142759
NCATS NIH HHS
Grant: UL1 TR001439
NIAID NIH HHS
Grant: R01 AI127744
NIAID NIH HHS
Grant: R43 AI145617
NIAID NIH HHS
Grant: T32 AI007526
NIAID NIH HHS
Grant: R41 AI136126
NIAID NIH HHS
Grant: R01 AI134907
National Institutes of Health
Grant: 3R01AI134907-03S2
A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery
National Institutes of Health
Grant: 5U19AI142759-04
Antiviral Drug Discovery and Development Center (AD3C)
National Institutes of Health
Grant: 1R43AI145617-01A1
Discovery and Development of Broad-spectrum Protease Inhibitors of Flaviviruses of Significant Public Health Threats
National Institutes of Health
Grant: 5UL1TR001439-07
UTMB Clinical and Translational Science Award
National Institutes of Health
Grant: 5R01AI127744-05
Revolutionary Eilat-based Chikungunya Vaccine Vector
National Institutes of Health
Grant: 5T32AI007526-10
Emerging and Tropical Infectious Diseases
National Institutes of Health
Grant: 5TL1TR001440-08
NRSA Training Core
National Institutes of Health
Grant: 5R41AI136126-02
Discovery of Zika virus therapeutics using a replicon assay
Amon G. Carter Foundation
National Institutes of Health
John S. Dunn Foundation
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
FWCI
3.58
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 1 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 7 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 7 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 6 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 4 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 3 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 4 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 5 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 6 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 5 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 2 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 2 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
Additional file 3 of Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells